The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: Protocol and clinical characteristics of the INCAS study

MLA

Brynte, C., et al. “The Clinical Course of Comorbid Substance Use Disorder and Attention Deficit/Hyperactivity Disorder: Protocol and Clinical Characteristics of the INCAS Study.” BMC Psychiatry, 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1366804453&authtype=sso&custid=ns315887.

APA

Brynte, C., Aeschlimann, M., Barta, C., Begeman, A. H. A., Bäcker, A., Crunelle, C. L., Daigre, C., De Fuentes-Merillas, L., Demetrovics, Z., Dom, G., López, L. G., Icick, R., Johnson, B., Joostens, P., Kapitány-Fövény, M., Karsinti, E., Kiefer, F., Konstenius, M., Levin, F. R., … Franck, J. (2022). The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: Protocol and clinical characteristics of the INCAS study. BMC Psychiatry.

Chicago

Brynte, C., M. Aeschlimann, C. Barta, A.H.A. Begeman, A. Bäcker, C.L. Crunelle, C. Daigre, et al. 2022. “The Clinical Course of Comorbid Substance Use Disorder and Attention Deficit/Hyperactivity Disorder: Protocol and Clinical Characteristics of the INCAS Study.” BMC Psychiatry. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1366804453&authtype=sso&custid=ns315887.